Corpus ID: 53467191

STUDIES FOR THE ORAL DELIVERY OF CALCITONIN

@inproceedings{2017STUDIESFT,
  title={STUDIES FOR THE ORAL DELIVERY OF CALCITONIN},
  author={},
  year={2017}
}
  • Published 2017
  • Nearly 95 years after the first unsuccessful attempts to deliver a peptide orally,1,2 research in this area has resulted in technologies that produce a clinically relevant oral bioavailability of only 1-2% for the majority of peptides studied,3 despite pharmaceutical and biotechnology companies expending a considerable amount of resources on oral peptide delivery. With the exception of small peptides such as taltirelin (Ceredist®)4 and desmopressin (Minirin®)5 or stable peptides such as… CONTINUE READING

    Figures and Tables from this paper.

    References

    SHOWING 1-10 OF 42 REFERENCES
    Influence of food intake on the bioavailability and efficacy of oral calcitonin.
    • 31
    Lessons learned from the clinical development of oral peptides
    • 35